Gano lokaci guda don kamuwa da cutar tarin fuka da juriya ga RIF & NIH

Tuberculosis (TB), wanda ke haifar da tarin fuka na Mycobacterium, ya kasance barazanar lafiyar duniya.Kuma karuwar juriya ga mahimman magungunan tarin fuka kamar Rifampicin (RIF) da Isoniazid (INH) yana da mahimmanci kuma yana daɗa cikas ga ƙoƙarin magance tarin tarin fuka a duniya.Gwajin gwaji mai sauri da daidaito na kwayoyin cutar tarin fuka da juriya ga RIF&INH ne WHO ta ba da shawarar don gano majinyatan da suka kamu da cutar kan lokaci tare da ba su magani mai dacewa cikin lokaci.

Kalubale

Kimanin mutane miliyan 10.6 ne suka kamu da cutar tarin fuka a shekarar 2021 tare da karuwar kashi 4.5% daga miliyan 10.1 a shekarar 2020, wanda ya yi sanadiyar mutuwar mutane miliyan 1.3, wanda ya kai 133 a cikin 100,000.

Tarin fuka mai jure wa ƙwayoyi, musamman MDR-TB (mai jurewa RIF & INH), yana ƙara yin tasiri ga maganin tarin fuka da rigakafin duniya.

Ana buƙatar ganewar cutar tarin fuka da RIF/INH cikin gaggawa don magani na farko kuma mafi inganci idan aka kwatanta da jinkirin sakamakon gwajin kamuwa da cutar.

Maganinmu

Marco & Micro-Test's Gano 3-in-1 TB don kamuwa da cutar tarin fuka/RIF & Gano Juriya na NIH Kityana ba da damar ingantaccen bincike na tarin fuka da RIF/INH a cikin ganowa ɗaya.

Fasahar narkewa tana gane gano tarin tarin fuka da MDR-TB lokaci guda.

3-in-1 TB/MDR-TB Gane gano kamuwa da cutar tarin fuka da kuma juriya na layin farko (RIF/INH) yana ba da damar maganin tarin fuka na lokaci kuma daidai.

Mycobacterium Tuberculosis Nucleic Acid da Rifampicin, Kit ɗin Gano Juriya na Isoniazid (Narkewar Curve)

Nasarar gane gwajin tarin fuka sau uku (cututtukan tarin fuka, RIF & NIH Resistance) a cikin ganowa ɗaya!

Mai saurisakamako:Akwai a cikin sa'o'i 1.5-2 tare da fassarar sakamako ta atomatik yana rage horon fasaha don aiki;

Misalin Gwaji:1-3 ml na ruwa;

Babban Hankali:Analytical hankali na 50 kwayoyin/ml don tarin fuka da 2x10³kwayoyin cuta / mL don RIF/INH resistant kwayoyin cuta, tabbatar da abin dogara ganowa ko da a low kwayoyin lodi.

Manufa da yawas: TB-IS6110;RIF-resistance -rpoB (507 ~ 503);

INH-resistance- InhA/AhpC/katG 315;

Tabbatar da Ingancin:Kulawar salula don ingantaccen ingancin samfurin don rage abubuwan karya;

Faɗin dacewa: Daidaituwa tare da yawancin tsarin PCR na yau da kullun don samun dama ga lab;

WHO ta Jagororin Biyayya: Bin ka'idodin WHO don kula da tarin fuka mai jure wa miyagun ƙwayoyi, tabbatar da aminci da dacewa a cikin aikin asibiti.